High Growth OTC Pharmaceutical Business - Capital Raise
| Categories: | Securities, Unissued Securities |
| Sale Type: | Asking Price |
| Price Guide: | AUD $3.5M (A$1.6M already raised) – Pre-money EV of A$11.7M |
| Status: | Closed |
Summary:
The Company is an owner and distributor of a portfolio of differentiated, cash-generative OTC pharmaceutical brands.
The Company has 8 core brands and recently acquired a category leading OTC dermatology brand which is cashflow accretive to the business. The Company is raising new equity to support development of new products from current brands; provide working capital for inventory; and increase sales and marketing spend. The management team has deep experience gained from senior leadership roles in major pharmaceutical companies and was successful in leading a PE-invested OTC pharmaceutical company, which was subsequently sold to a multinational pharmaceutical firm realising significant returns for investors.
Driven by acquisition and organic growth, the Company aims to become a A$100M revenue and 18%+ EBIT company in 5 years, creating an attractive target for a strategic buyer, PE investor or a potential IPO.
Share this Listing